IL103040A0 - Heterocyclically substituted quinolylmethoxy-phenylacetamides,their preparation and pharmaceutical compositions containing them - Google Patents

Heterocyclically substituted quinolylmethoxy-phenylacetamides,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL103040A0
IL103040A0 IL103040A IL10304092A IL103040A0 IL 103040 A0 IL103040 A0 IL 103040A0 IL 103040 A IL103040 A IL 103040A IL 10304092 A IL10304092 A IL 10304092A IL 103040 A0 IL103040 A0 IL 103040A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
phenylacetamides
preparation
compositions containing
heterocyclically substituted
Prior art date
Application number
IL103040A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL103040A0 publication Critical patent/IL103040A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL103040A 1991-09-06 1992-09-03 Heterocyclically substituted quinolylmethoxy-phenylacetamides,their preparation and pharmaceutical compositions containing them IL103040A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4129742A DE4129742A1 (de) 1991-09-06 1991-09-06 Heterocyclisch substituierte chinolylmethoxy-phenylacetamide

Publications (1)

Publication Number Publication Date
IL103040A0 true IL103040A0 (en) 1993-02-21

Family

ID=6440067

Family Applications (1)

Application Number Title Priority Date Filing Date
IL103040A IL103040A0 (en) 1991-09-06 1992-09-03 Heterocyclically substituted quinolylmethoxy-phenylacetamides,their preparation and pharmaceutical compositions containing them

Country Status (19)

Country Link
US (1) US5266578A (xx)
EP (1) EP0530639B1 (xx)
JP (1) JPH05194403A (xx)
KR (1) KR930006004A (xx)
CN (1) CN1070190A (xx)
AT (1) ATE110070T1 (xx)
AU (1) AU649351B2 (xx)
CA (1) CA2077465A1 (xx)
CZ (1) CZ276092A3 (xx)
DE (2) DE4129742A1 (xx)
DK (1) DK0530639T3 (xx)
ES (1) ES2057953T3 (xx)
FI (1) FI923968A (xx)
HU (1) HUT65660A (xx)
IL (1) IL103040A0 (xx)
MX (1) MX9204913A (xx)
NO (1) NO923181L (xx)
NZ (1) NZ244225A (xx)
TW (1) TW221431B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4219765A1 (de) * 1992-06-17 1993-12-23 Bayer Ag Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate
ES2062943B1 (es) * 1993-03-23 1995-11-16 Uriach & Cia Sa J Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas.
DE69422450T2 (de) * 1993-06-29 2000-06-08 Takeda Chemical Industries Ltd Chinoline oder Chinazolin-Derivate und deren Verwendung zur Herstellung eines Medikaments für die Behandlung von Osteoporose
ES2103180B1 (es) * 1994-08-01 1998-04-01 Menarini Lab Fenilacetamidas con accion antagonista de los leucotrienos.
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
EP0725063A1 (de) * 1995-02-01 1996-08-07 Ciba-Geigy Ag Chinolin-Derivate
US6121300A (en) 1998-11-10 2000-09-19 Wagle; Dilip R. Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
US6399641B1 (en) * 2000-07-13 2002-06-04 Hoffmann-La Roche Inc. 2H-tetrazole-amide compounds with therapeutic activity as metabotropic glutamate receptor agonists
WO2005026137A2 (en) * 2003-09-06 2005-03-24 Vertex Pharmaceuticals Incorporated Modulators of atp-binding cassette transporters
KR102393675B1 (ko) * 2021-08-20 2022-05-11 (주)삼우공간건축사사무소 공동주택용 세대현관의 안전바닥패널

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3783105T2 (de) * 1986-03-13 1993-04-22 Rhone Poulenc Rorer Int Chinolinylaether tetrazole als mittel zur behandlung von hyperempfindlichen krankheiten.
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
US5102881A (en) * 1988-06-27 1992-04-07 Merck Frosst Canada, Inc. Quinoline ether alkanoic acids
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5041453A (en) * 1990-05-30 1991-08-20 Rhone-Poulenc Rorer Pharmaceuticals Inc. Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene D4

Also Published As

Publication number Publication date
NO923181D0 (no) 1992-08-14
DE59200387D1 (de) 1994-09-22
EP0530639A1 (de) 1993-03-10
DE4129742A1 (de) 1993-03-11
CA2077465A1 (en) 1993-03-07
CN1070190A (zh) 1993-03-24
AU649351B2 (en) 1994-05-19
US5266578A (en) 1993-11-30
AU2205492A (en) 1993-03-11
ATE110070T1 (de) 1994-09-15
KR930006004A (ko) 1993-04-20
EP0530639B1 (de) 1994-08-17
NO923181L (no) 1993-03-08
JPH05194403A (ja) 1993-08-03
NZ244225A (en) 1994-08-26
FI923968A (fi) 1993-03-07
DK0530639T3 (da) 1994-12-05
CZ276092A3 (en) 1993-06-16
FI923968A0 (fi) 1992-09-04
MX9204913A (es) 1993-03-01
HUT65660A (en) 1994-07-28
HU9202850D0 (en) 1992-11-30
TW221431B (xx) 1994-03-01
ES2057953T3 (es) 1994-10-16

Similar Documents

Publication Publication Date Title
IL108436A0 (en) Five-membered heterocycles, their preparation and pharmaceutical compositions containing them
MY104685A (en) Substituted thiazoles and their use as fungicides.
GR3018541T3 (en) Condensed heterocyclic compounds and their use in therapy.
IL64885A (en) 3,20-dioxo-1,4-pregnadiene-17alpha-ol-17-aromatic heterocyclic esters,their preparation and pharmaceutical compositions containing them
AU639611B2 (en) Saturated hydroxyalkylquinoline acids as leukotriene antagonists
PT79840A (en) Process for the preparation of polipeptides with alpha-amilase inhibiting action and pharmaceutical compositions therewith
ES2113636T3 (es) Trioles sustituidos.
IL103040A0 (en) Heterocyclically substituted quinolylmethoxy-phenylacetamides,their preparation and pharmaceutical compositions containing them
AU542902B2 (en) Substituted carboxylic ceto-acids, process for the preparation thereof, use thereof and medicinal compositions containing them
ES2062145T3 (es) 1,8-naftiridinas substituidas.
DE3318789C2 (xx)
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
AU1243392A (en) Prostacycline and carbacycline derivatives as agents for treating feverish complaints
IE893157L (en) Stable oxapenem-3-carboxylic acids and their use as¹ß-lactamase inhibitors
BR9205351A (pt) Composição líquida contendo éster carboxílico complexo.
MX9200872A (es) Composicion de bis-bibenzimidazol.
ES485992A1 (es) Procedimiento para la obtencion de un fungicida a base de carboximidas y derivados sulfamidicos
ATE42743T1 (de) Thiochromanderivat, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
DE3824939A1 (de) Neue 2,2-dihalogencyclopropylhydroxyethyltriazole enthaltende antimykotische mittel
HUT62447A (en) Composition disinfecting and indicating body paris
ZA924925B (en) The use of organic compounds in dermatological compositions
AU639610C (en) Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
ES1023371Y (es) Contenedor involcable de doble uso perfeccionado.
IL96293A0 (en) Pharmaceutical compositions containing fatty acids and methods for the use thereof